BHARAT IMMUNOLOGICALS Financial Statements Trends

This module enables investors to look at BHARAT IMMUNOLOGICALS various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing BHARAT IMMUNOLOGICALS Valuation or Volatility. It can also complement various BHARAT IMMUNOLOGICALS Technical models. Check also Trending Equities.

BHARAT IMMUNOLOGICALS Cash per Share Analysis

Cash per Share is a ratio of current cash on hands or in the banks of the company to total number of shares outstanding. It is used to determine firm's liquidity and is a good indicator of overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Cash per Share 
 = 
Total Cash 
Average Shares 
More About Cash per Share | All Equity Analysis
BHARAT IMMUNOLOGICALS Cash per Share  =
4.25 
BHARAT IMMUNOLOGICALS ValuationFundamentalsBuy or Sell

About Cash per Share

Companies with high Cash per Share ratio will be considered as attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentalsCompare to competition
In accordance with recently published financial statements BHARAT IMMUNOLOGICALS BIOLOG has Cash per Share of 4.25 times. This is 2.3% lower than that of the Healthcare sector, and about the same as Biotechnology (which currently averages 4.33) industry, The Cash per Share for all stocks is 15.17% higher than the company.

BHARAT IMMUNOLOGICALS Fundamental Drivers Relationships

BHARAT IMMUNOLOGICALS BIOLOG is number one stock in price to sales category among related companies. It is number one stock in earnings per share category among related companies .
Search macroaxis.com